More than half of patients who had bariatric surgery stayed in diabetes remission, according to Medscape, which published the report on Tuesday, October 13, 2026.
The finding covers patients whose diabetes went into remission after the operation and who had not returned to an active diabetic state at the time of the reporting. Medscape did not disclose in the headline or summary how many patients were studied, how long they were followed, or which surgical procedures were involved.
The result adds to the ongoing discussion about how durable the metabolic effects of weight-loss surgery are for people with type 2 diabetes. Remission in this context generally means blood sugar levels return to a non-diabetic range without the need for diabetes medication, though the source material did not define the term as used in the report.
Bariatric surgery has long been associated with improved blood sugar control in patients with obesity and type 2 diabetes, and the question of whether those gains hold up over years rather than months has been a central point of debate among clinicians.
Medscape's report indicates that for a majority of patients in the group examined, remission was still in place. The publication did not provide further breakdowns in the material available.
What to watch next: the full Medscape report for details on study size, follow-up duration, and the specific surgical techniques linked to lasting remission.
